Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-25-000609
Filing Date
2025-05-15
Accepted
2025-05-15 17:19:11
Documents
1
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 3871
  Complete submission text file 0001593968-25-000609.txt   5482
Mailing Address C/O ACELYRIN, INC. 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address
Lin Shao-Lee (Reporting) CIK: 0001725092 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39635 | Film No.: 25955824

Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Issuer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)